Hauge C, Breitschaft A, Hartoft-Nielsen ML, Jensen S, Baekdal T
Studies have found that GLP-1R is widely distributed on pancreatic and other tissues and has multiple biological effects, such as reducing neuroinflammation, promoting nerve growth, improving heart function, suppressing appetite, delaying gastric emptying, regulating blood lipid metabolism, and reducing fat deposition
This risk applies to any weight-loss method whether diet-based or medication-assisted
Compounded weight-loss drugs are a growing problem for state regulators Last August, North Carolina began covering some federal Food and Drug Administration-approved GLP-1s for obesity treatment among some populations
Adjusting the schedule based on tolerance The schedule above is a template, not a rigid prescription